{ "as_of": "2026-11-06", "cmr": "uk-cm-kg/AIM/NCYT", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# NOVACYT S.A. (AIM: NCYT) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is NOVACYT S.A., listed on AIM under ticker NCYT, with ISIN FR0010397232 and LEI 213800BWAC2BF295EG28. Its security type is Corporate, its segment is AMSM, its sector is Medical Equipment and Services [201020], and its jurisdiction is France (FR). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 30 filings in the twelve months to 2026-11-06, across 26 filing days. The median gap between filing days is 9 days, against a median of 7.0 days for AIM and 6 days for the sector. The latest filing is dated 2026-11-02 and is of type corporate action, 4 days before the record date, against a median latency of 4 days for AIM and 2 days for the sector. The record holds 33.5 filings as the median for AIM and 33 as the median for the sector.\n\n## Auditor\n\nThe auditor of record is Deloitte LLP. The auditor's location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record. The record does not carry a lifecycle type map for this register. The halt flag reads listed, not halted.\n\n## Orderability\n\nFor elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read. The count is 0.\n\n## Open research\n\nThe record holds 5 openly published research notes. They are from SP Angel Healthcare dated 2021-02-04 and 2020-10-21, from Stifel dated 2017-02-23 and 2016-07-22, and from Invest Securities dated 2016-05-20.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nNo years are sealed for the issuer, and the market's vintage is not sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of answer is not_sealed.\n\n## Sources\n\n15 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/NCYT (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/213800BWAC2BF295EG28 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/NCYT/novacyt-s-a/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/NCYT (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://novacyt.com/wp-content/uploads/2024/09/Novacyt-Annual-Report-and-Accounts-for-the-year-ended-2020.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://novacyt.com/wp-content/uploads/2021/02/SP-Angel-Update-04.02.2021.pdf (open research)\n- https://novacyt.com/wp-content/uploads/2022/05/2020_Oct_SP_Angel_Novacyt_Initiation_Note_21.10.2020.pdf (open research)\n- https://novacyt.com/wp-content/uploads/2017/05/Stifel-Novacyt-update-23.02.17.pdf (open research)\n- https://novacyt.com/wp-content/uploads/2016/07/Stifel-Research-Note-on-Novacyt-22.07.16.pdf (open research)\n- http://novacyt.com/wp-content/uploads/2016/06/INVEST-SECURITIES-NOVACYT-research-note.pdf (open research)\n- https://mcp.uk-cm-kg.ai/record/AIM/NCYT (the record)\n", "market": "UK", "node": "uk-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-11", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "Tavily regex", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://novacyt.com/wp-content/uploads/2024/09/Novacyt-Annual-Report-and-Accounts-for-the-year-ended-2020.pdf", "state": "sourced", "value": "Deloitte LLP" }, "auditor_firm_id": { "market": "UK", "state": "not_on_record" }, "auditor_location": { "market": "UK", "state": "not_on_record" }, "changes": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "cmr": "uk-cm-kg/AIM/NCYT", "coverage": { "count": 0, "houses": [], "pages_checked": [ { "page": "https://novacyt.com/investors/", "result": "read: 0 of 1 named houses found on the page" } ], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 594, "median_cadence_gap_days": 7, "median_filings": 33.5, "median_latency_days": 4, "name": "AIM" }, "sector": { "issuers": 17, "median_cadence_gap_days": 6, "median_filings": 33, "median_latency_days": 2, "name": "Medical Equipment and Services [201020]" } }, "by_type": { "agm_record_date": 3, "corporate_action": 7, "director_dealing": 2, "financial_statement": 3, "regulatory_announcement": 15 }, "cadence_median_gap_days": 9, "filing_days": 26, "filings": 30, "latency_days": 4, "latest": [ { "category": null, "date": "2026-11-02", "source": "https://www.investegate.co.uk/announcement/rns/novacyt-s-a-cdi---ncyt/liquidity-agreement-and-total-voting-rights/9853827", "title": "Liquidity Agreement and Total Voting Rights", "type": "corporate_action" }, { "category": null, "date": "2026-09-08", "source": "https://www.investegate.co.uk/announcement/rns/novacyt-s-a-cdi---ncyt/launch-of-ivdr-certified-yourgene-dpyd-assay/9759938", "title": "Launch of IVDR-Certified Yourgene® DPYD Assay", "type": "regulatory_announcement" }, { "category": null, "date": "2026-09-01", "source": "https://www.investegate.co.uk/announcement/rns/novacyt-s-a-cdi---ncyt/total-voting-rights/9749697", "title": "Total Voting Rights", "type": "corporate_action" }, { "category": null, "date": "2026-09-01", "source": "https://www.investegate.co.uk/announcement/rns/novacyt-s-a-cdi---ncyt/master-collaboration-agreement-with-illumina/9747179", "title": "Master Collaboration Agreement with Illumina", "type": "regulatory_announcement" }, { "category": null, "date": "2026-08-03", "source": "https://www.investegate.co.uk/announcement/rns/novacyt-s-a-cdi---ncyt/liquidity-agreement-update-and-total-voting-rights/9701529", "title": "Liquidity Agreement Update and Total Voting Rights", "type": "corporate_action" } ], "latest_filing_date": "2026-11-02", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.uk-cm-kg.ai/events/AIM/NCYT", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "AIM" }, "isin": { "read_by": "LSE instrument reference record (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/NCYT", "state": "confirmed", "value": "FR0010397232" }, "jurisdiction": { "read_by": "GLEIF LEI record (LEI per the LEI column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.gleif.org/api/v1/lei-records/213800BWAC2BF295EG28", "state": "sourced", "value": "France (FR)" }, "lei": { "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN", "read_date": "2026-11-09", "read_date_basis": "the field", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN FR0010397232)", "state": "sourced", "value": "213800BWAC2BF295EG28" }, "name": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "NOVACYT S.A." }, "sector": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/NCYT/novacyt-s-a/company-page", "state": "sourced", "value": "Medical Equipment and Services [201020]" }, "security_type": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "Corporate" }, "segment": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "AMSM" }, "ticker": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "NCYT" }, "website": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/NCYT/novacyt-s-a/company-page", "state": "sourced", "value": "http://www.novacyt.com" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "domicile_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "listing": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "name_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "segment_move": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "market": "UK", "node": "uk-cm-kg", "numbers_hash": "sha256:ddb202017cb3c1de23a4728efbc7412af3670278d65b2d6807092cfae8226360", "open_research": { "read_date": "2026-11-12", "rows": [ { "date": "2021-02-04", "kind": "issuer-sponsored", "publisher": "SP Angel Healthcare", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://novacyt.com/wp-content/uploads/2021/02/SP-Angel-Update-04.02.2021.pdf", "state": "sourced", "title": "Novacyt – Update Note" }, { "date": "2020-10-21", "kind": "issuer-sponsored", "publisher": "SP Angel Healthcare", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://novacyt.com/wp-content/uploads/2022/05/2020_Oct_SP_Angel_Novacyt_Initiation_Note_21.10.2020.pdf", "state": "sourced", "title": "Novacyt Initiation of Coverage" }, { "date": "2017-02-23", "kind": "independent", "publisher": "Stifel", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://novacyt.com/wp-content/uploads/2017/05/Stifel-Novacyt-update-23.02.17.pdf", "state": "sourced", "title": "Novacyt SA ALNOV FP BUY" }, { "date": "2016-07-22", "kind": "independent", "publisher": "Stifel", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://novacyt.com/wp-content/uploads/2016/07/Stifel-Research-Note-on-Novacyt-22.07.16.pdf", "state": "sourced", "title": "Novacyt SA BUY" }, { "date": "2016-05-20", "kind": "independent", "publisher": "Invest Securities", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "http://novacyt.com/wp-content/uploads/2016/06/INVEST-SECURITIES-NOVACYT-research-note.pdf", "state": "sourced", "title": "NOVACYT (+)" } ], "state": "found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "elective professional client", "eligible counterparty" ], "outcomes": { "elective professional client": { "determinable": true, "signal": "ACM-200" }, "eligible counterparty": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json", "door": "https://mcp.uk-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1", "section": "uk.aio.v16" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.uk-cm-kg.ai/record/AIM/NCYT", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-09", "source": "https://marketsecurities.fca.org.uk/officiallist", "value": "listed, not halted" } }, "numbers_hash": "sha256:ddb202017cb3c1de23a4728efbc7412af3670278d65b2d6807092cfae8226360", "path": "/uk/AIM/NCYT", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is NOVACYT S.A., listed on AIM under ticker NCYT, with ISIN FR0010397232 and LEI 213800BWAC2BF295EG28. Its security type is Corporate, its segment is AMSM, its sector is Medical Equipment and Services [201020], and its jurisdiction is France (FR). Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 30 filings in the twelve months to 2026-11-06, across 26 filing days. The median gap between filing days is 9 days, against a median of 7.0 days for AIM and 6 days for the sector. The latest filing is dated 2026-11-02 and is of type corporate action, 4 days before the record date, against a median latency of 4 days for AIM and 2 days for the sector. The record holds 33.5 filings as the median for AIM and 33 as the median for the sector.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Deloitte LLP. The auditor's location is not on the record. Auditor changes are not on the record.", "title": "Auditor" }, { "id": "events", "text": "Listing, delisting, name change, domicile change and segment move are not on the record. The record does not carry a lifecycle type map for this register. The halt flag reads listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the issuer's investor-relations pages read. The count is 0.", "title": "Coverage" }, { "id": "open_research", "text": "The record holds 5 openly published research notes. They are from SP Angel Healthcare dated 2021-02-04 and 2020-10-21, from Stifel dated 2017-02-23 and 2016-07-22, and from Invest Securities dated 2016-05-20.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "No years are sealed for the issuer, and the market's vintage is not sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of answer is not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "15 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer" }, { "for": "identity.isin", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/NCYT" }, { "for": "identity.jurisdiction", "source": "https://api.gleif.org/api/v1/lei-records/213800BWAC2BF295EG28" }, { "for": "identity.lei", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download" }, { "for": "identity.sector", "source": "https://www.londonstockexchange.com/stock/NCYT/novacyt-s-a/company-page" }, { "for": "the disclosure lines", "source": "https://mcp.uk-cm-kg.ai/events/AIM/NCYT" }, { "for": "the halt flag", "source": "https://marketsecurities.fca.org.uk/officiallist" }, { "for": "the auditor", "source": "https://novacyt.com/wp-content/uploads/2024/09/Novacyt-Annual-Report-and-Accounts-for-the-year-ended-2020.pdf" }, { "for": "the orderability chapter", "source": "https://mcp.uk-cm-kg.ai/book/aio.json" }, { "for": "open research", "source": "https://novacyt.com/wp-content/uploads/2021/02/SP-Angel-Update-04.02.2021.pdf" }, { "for": "open research", "source": "https://novacyt.com/wp-content/uploads/2022/05/2020_Oct_SP_Angel_Novacyt_Initiation_Note_21.10.2020.pdf" }, { "for": "open research", "source": "https://novacyt.com/wp-content/uploads/2017/05/Stifel-Novacyt-update-23.02.17.pdf" }, { "for": "open research", "source": "https://novacyt.com/wp-content/uploads/2016/07/Stifel-Research-Note-on-Novacyt-22.07.16.pdf" }, { "for": "open research", "source": "http://novacyt.com/wp-content/uploads/2016/06/INVEST-SECURITIES-NOVACYT-research-note.pdf" }, { "for": "the record", "source": "https://mcp.uk-cm-kg.ai/record/AIM/NCYT" } ], "title": "NOVACYT S.A. (NCYT) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }